BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 12028623)

  • 1. Percutaneous nephrostomy versus indwelling ureteral stents in patients with bilateral nongenitourinary malignant extrinsic obstruction.
    Park DS; Park JH; Lee YT
    J Endourol; 2002 Apr; 16(3):153-4. PubMed ID: 12028623
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Percutaneous nephrostomy versus indwelling ureteral stents in the management of extrinsic ureteral obstruction in advanced malignancies: are there differences?
    Ku JH; Lee SW; Jeon HG; Kim HH; Oh SJ
    Urology; 2004 Nov; 64(5):895-9. PubMed ID: 15533473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Percutaneous nephrostomy versus indwelling ureteral stent in the management of gynecological malignancies.
    Song Y; Fei X; Song Y
    Int J Gynecol Cancer; 2012 May; 22(4):697-702. PubMed ID: 22315095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Management of ureteral obstruction : Value of percutaneous nephrostomy and ureteral stents].
    Netsch C; Becker B; Gross AJ
    Urologe A; 2016 Nov; 55(11):1497-1510. PubMed ID: 27787581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Endoscopic management of bilateral ureteral obstruction after radiotherapy].
    Zeng GH; Li X; Wu KJ; Chen WZ
    Ai Zheng; 2004 Jan; 23(1):108-9. PubMed ID: 14720387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of extrinsic malignant ureteral obstruction with urinary diversion.
    Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
    Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wire-reinforced ureteral stents to rescue from nephrostomy tube in extrinsic ureteral obstruction.
    Dauw CA; Faerber GJ; Hollingsworth JM; Wolf JS
    Can J Urol; 2015 Jun; 22(3):7806-10. PubMed ID: 26068630
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ureteral metal stents: 10-year experience with malignant ureteral obstruction treatment.
    Liatsikos EN; Karnabatidis D; Katsanos K; Kallidonis P; Katsakiori P; Kagadis GC; Christeas N; Papathanassiou Z; Perimenis P; Siablis D
    J Urol; 2009 Dec; 182(6):2613-7. PubMed ID: 19836807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The management of malignant ureteral obstruction treated with ureteral stents.
    Ganatra AM; Loughlin KR
    J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of indwelling metallic stents for malignant extrinsic ureteral obstruction.
    Asakawa J; Iguchi T; Tamada S; Ninomiya N; Kato M; Yamasaki T; Nakatani T
    Int J Urol; 2018 Mar; 25(3):258-262. PubMed ID: 29194771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of full-length metallic stents in malignant ureteral obstruction.
    Abbasi A; Wyre HW; Ogan K
    J Endourol; 2013 May; 27(5):640-5. PubMed ID: 23237309
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
    Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
    Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Percutaneous urinary drainage and ureteric stenting in malignant disease.
    Allen DJ; Longhorn SE; Philp T; Smith RD; Choong S
    Clin Oncol (R Coll Radiol); 2010 Nov; 22(9):733-9. PubMed ID: 20728326
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Palliative Subcutaneous Tunneled Nephrostomy Tube (PSTN): a simple and effective technique for management of malignant extrinsic ureteral obstruction.
    Bell DG; Fischer MA
    Can J Urol; 2002 Feb; 9(1):1470-4. PubMed ID: 11886602
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gastric cancer with obstructive uropathy: clinical experience with 17 cases.
    Liaw CC; Chuang CK; Chen JS; Chang HK
    Changgeng Yi Xue Za Zhi; 1997 Dec; 20(4):286-92. PubMed ID: 9509657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The double-J ureteral stent: in vivo and in vitro flow studies.
    Hübner WA; Plas EG; Stoller ML
    J Urol; 1992 Aug; 148(2 Pt 1):278-80. PubMed ID: 1635117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tandem Ureteral Stents for Malignant Ureteral Obstruction.
    Haifler M; Shvero A; Zilberman D; Ramon J; Winkler H; Margel D; Kleinmann N
    J Endourol; 2020 Feb; 34(2):222-226. PubMed ID: 31724450
    [No Abstract]   [Full Text] [Related]  

  • 19. Ureteral decompression in advanced nonurologic malignancies.
    Donat SM; Russo P
    Ann Surg Oncol; 1996 Jul; 3(4):393-9. PubMed ID: 8790853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous nephrostomy for ureteral obstruction in patients with gynecologic malignancy.
    Coddington CC; Thomas JR; Hoskins WJ
    Gynecol Oncol; 1984 Jul; 18(3):339-48. PubMed ID: 6204911
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.